Information  X 
Enter a valid email address

MaxCyteIncStk $0.01DI (MXCT)

Date Time Source Announcement
14 Aug 2019 7:00 am
RNS
Notice of Results
  7:00 am
RNS
Notice of Results
17 Jul 2019 7:00 am
RNS
Trading Update
  7:00 am
RNS
Trading Update
11 Jul 2019 7:00 am
RNS
MaxCyte to Host Capital Markets Day Today
  7:00 am
RNS
MaxCyte to Host Capital Markets Day Today
05 Jul 2019 4:42 pm
RNS
Second Price Monitoring Extn
  4:42 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  4:36 pm
RNS
Price Monitoring Extension
19 Jun 2019 7:00 am
RNS
Annual Report
  7:00 am
RNS
Annual Report
12 Jun 2019 7:00 am
RNS
Appointment of Joint Corporate Broker
  7:00 am
RNS
Appointment of Joint Corporate Broker
29 May 2019 7:00 am
RNS
Save the Date: Capital Markets Day
08 May 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  4:36 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Phase I Clinical Trial of MCY-M11 Progressed
  7:00 am
RNS
Phase I Clinical Trial of MCY-M11 Progressed
01 May 2019 7:00 am
RNS
ASGCT Presentation on First CARMA Drug Candidate
24 Apr 2019 7:00 am
RNS
Final Results for Year Ended 31 December 2018
  7:00 am
RNS
Final Results for Year Ended 31 December 2018
08 Apr 2019 7:00 am
RNS
Launch of ExPERTT Instrument Family
  7:00 am
RNS
Launch of ExPERTT Instrument Family
26 Mar 2019 7:00 am
RNS
Notice of Full Year Results
  7:00 am
RNS
Notice of Full Year Results
19 Mar 2019 5:05 pm
RNS
Director Dealings
  5:05 pm
RNS
Director Dealings
05 Mar 2019 7:00 am
RNS
Grant of Options
  7:00 am
RNS
Grant of Options
01 Mar 2019 7:00 am
RNS
Clinical & Commercial Agreement with Kite
  7:00 am
RNS
Clinical & Commercial Agreement with Kite
26 Feb 2019 5:32 pm
RNS
Result of Special Meeting and Issue of Equity
  5:32 pm
RNS
Result of Special Meeting and Issue of Equity
05 Feb 2019 4:32 pm
RNS
Results of Placing
  4:32 pm
RNS
Results of Placing
  7:00 am
RNS
Proposed Placing to raise a minimum of �10 million
  7:00 am
RNS
Proposed Placing to raise a minimum of �10 million
15 Jan 2019 7:00 am
RNS
Trading Update
  7:00 am
RNS
Trading Update
19 Dec 2018 7:00 am
RNS
Change of Auditor
  7:00 am
RNS
Change of Auditor
17 Dec 2018 6:06 pm
RNS
Director Dealings
  6:06 pm
RNS
Director Dealings
21 Nov 2018 7:00 am
RNS
Consolidation of Trading Lines
20 Nov 2018 7:00 am
RNS
Block Admission Six Monthly Return/TVR
16 Nov 2018 7:00 am
RNS
Webinar: non-viral cell engineering
14 Nov 2018 7:00 am
RNS
Clinical and Commercial License Agreement
12 Nov 2018 7:00 am
RNS
MaxCyte Announces Research Agreement with Kite
09 Nov 2018 7:00 am
RNS
Expansion of CRISPR Commercial License Agreement
31 Oct 2018 4:25 pm
RNS
Result of AGM
10 Oct 2018 7:00 am
RNS
Dosing Begins in First Clinical Trial of MCY-M11
08 Oct 2018 7:00 am
RNS
Notice of AGM
24 Sep 2018 7:00 am
RNS
Results for the Half Year ended 30 June 2018
10 Sep 2018 7:00 am
RNS
Grant of Options
03 Sep 2018 7:00 am
RNS
Notice of Half Year Results
26 Jul 2018 5:33 pm
RNS
Director/PDMR Shareholding
16 Jul 2018 7:00 am
RNS
FDA IND Clearance for First Clinical Programme
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t